Skip to content

Study Details

C4671026: Study drugs for Children with COVID-19 in Children

(IRB#: IRB_00155069)

Nirmatrelvir and Ritonavir are study drugs for children with COVID-19. These study drugs are only approved by the federal drug administration (FDA) for adults. Research is needed to learn the effectiveness of the study drugs and find the best dose for children with COVID-19.


  • All genders
  • All Ages
  • Volunteers with special conditions
  •   In Person
  • Paid

Who can participate?

 Gender: All genders

  Age: All Ages

  Volunteers: Volunteers with special conditions

   Location: In Person

Inclusion Criteria

  • Ages 0 to 17 years old
  • Child with COVID-19
  • At least one health issue that increases the risk of COVID-19
  • In person at the University of Utah

Exclusion Criteria

  • Hospitalized for COVID-19
  • Mental health condition within the past year before participation
  • Medical condition or infection that may require being in the hospital or surgery

Will I be paid for my time?


For more information contact:

Abbey Loveridge


IRB#: IRB_00155069

PI: Justin Alvey


Approval Date: 2022-12-21 07:00:00

Study Categories: COVID-19 Studies

Specialties: Infectious Diseases

Last Updated: 6/8/23